Journal of Cataract & Refractive Surgery
Volume 32, Issue 3 , Pages 396-406 , March 2006

ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study

,Accepted 28 November 2005.

References 

  1. ESCRS Guidelines on Prophylaxis, Management and Therapy of Post-operative Endophthalmitis. Dublin, European Society of Cataract & Refractive Surgeons, version 1, 2005
  2. Taban M, Behrens A, Newcomb RL, et al. Acute endophthalmitis following cataract surgery; a systematic review of the literature. Arch Ophthalmol. 2005;123:613–620
  3. Khan RI, Kennedy S, Barry P. Incidence of presumed postoperative endophthalmitis in Dublin for a 5-year period (1997–2001). J Cataract Refract Surg. 2005;31:1575–1581
  4. Nagaki Y, Hayasaka S, Kadoi C, et al. Bacterial endophthalmitis after small-incision cataract surgery; effect of incision placement and intraocular lens type. J Cataract Refract Surg. 2003;29:20–26
  5. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery; an evidence-based update. Ophthalmology. 2002;109:13–24
  6. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98:1769–1775
  7. Miño de Kaspar H, Chang RT, Singh K, et al. Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery. Arch Ophthalmol. 2005;123:161–165
  8. Peyman GA, Lee PJ, Seal DV. Endophthalmitis Diagnosis and Management. London, New York, NY: Taylor & Francis; 2004;
  9. Gimbel HV, Sun R, de Brof BM. Prophylactic intracameral antibiotics during cataract surgery; the incidence of endophthalmitis and corneal endothelial cell loss. Eur J Implant Refract Surg. 1994;6:280–285
  10. Schmitz S, Dick HB, Krummenauer F, Pfeiffer N. Endophthalmitis in cataract surgery; results of a German survey. Ophthalmology. 1999;106:1869–1877
  11. Morlet N, Gatus B, Coroneo M. Patterns of peri-operative prophylaxis for cataract surgery: a survey of Australian ophthalmologists. Aust NZ J Ophthalmol. 1998;26:5–12
  12. Centers for Disease Control . Recommendations for preventing the spread of vancomycin resistance. MMWR Recomm Rep. 1995;44(RR-12):1–13
  13. Wallin T, Parker J, Jin Y, et al. Cohort study of 27 cases of endophthalmitis at a single institution. J Cataract Refract Surg. 2005;31:735–741
  14. Rubio EF. Climatic influence on conjunctival bacteria of patients undergoing cataract surgery. Eye. 2004;18:778–784
  15. Mayer E, Cadman D, Ewings P, et al. A 10 year retrospective study of cataract surgery and endophthalmitis in a single eye unit: injectable lenses lower the incidence of endophthalmitis. Br J Ophthalmol. 2003;87:867–869
  16. Montan PG, Wejde G, Koranyi G, Rylander M. Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg. 2002;28:977–981
  17. Montan PG, Wejde G, Setterquist H, et al. Prophylactic intracameral cefuroxime; evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg. 2002;28:982–987
  18. Jensen MK, Fiscella RG, Crandall AS, et al. A retrospective study of endophthalmitis rates comparing quinolone antibiotics. Am J Ophthalmol. 2005;139:141–148
  19. Koch H-R, Kulus SC, Roessler M, et al. Corneal penetration of fluoroquinolones: aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops. J Cataract Refract Surg. 2005;31:1377–1385
  20. Bucci FA. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification. Am J Ophthalmol. 2004;137:308–312
  21. Colin J, Simonpoli S, Geldsetzer K, Ropo A. Corneal penetration of levofloxacin into the human aqueous humour: a comparison with ciprofloxacin. Acta Ophthalmol Scand. 2003;81:611–613
  22. Raizman MB, Rubin JM, Graves AL, Rinehart M. Tear concentrations of levofloxacin following topical administration of a single dose of 0.5% levofloxacin ophthalmic solution in healthy volunteers. Clin Ther. 2002;24:1439–1450
  23. Graves A, Henry M, O'Brien TP, et al. In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones. Cornea. 2001;20:301–305errata, 546
  24. Zar JH. Biostatistical Analysis. 4th ed.. Upper Saddle River, NJ: Prentice Hall; 1999;
  25. Monson MC, Mamalis N, Olson RJ. Toxic anterior segment inflammation following cataract surgery. J Cataract Refract Surg. 1992;18:184–189
  26. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley; 1989;
  27. Ellenburg SS, Fleming TR, DeMets DL. Data Monitoring Committees in Clinical Trials: a Practical Perspective. New York, NY: John Wiley; 2002;
  28. West ES, Behrens A, McDonnell PJ, et al. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology. 2005;112:1388–1394
  29. Johnston RL, Sparrow JM, Canning CR, et al. Pilot National Electronic Cataract Surgery Survey: I. Method, descriptive, and process features. Eye. 2005;19:788–794
  30. Flory J, Emanuel E. Interventions to improve research participants' understanding in informed consent for research; a systematic review. JAMA. 2004;292:1593–1601
  31. Barry P, Seal DV, Gettinby G, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study. J Cataract Refract Surg. 2006;32:407–410
  32. Abbasi K. Compulsory registration of clinical trials. BMJ. 2004;329:637–638

 Funded by the European Society of Cataract & Refractive Surgeons, Dublin, Ireland, with support from Santen GmbH, Germering, Germany.No author has a financial or proprietary interest in any material or method mentioned.The Board of the ESCRS, through its current and recent officers and members, acknowledges several individuals: Peter Barry for conceiving the study and ensuring it became a reality; David Seal for his academic input, tenacity, and voluntary service; and Fiona Lees for meticulous collection and recording of data. The Board acknowledges the contribution of the partners and the doctors, nurses, pharmacists, microbiologists, secretaries, and assistants who have coped magnificently with the additional workload imposed on them by participation in the multicenter study. The Board also acknowledges the promptness and diligence with which the Data Management Committee consistently responded to the electronic information presented to them. In addition, the Board acknowledges the financial contribution of Santen. Finally, the Board acknowledges Mary D'Ardis, CEO, and the ESCRS staff for their unremitting enthusiasm and support.

PII: S0886-3350(06)00160-X

doi: 10.1016/j.jcrs.2006.02.014

Journal of Cataract & Refractive Surgery
Volume 32, Issue 3 , Pages 396-406 , March 2006

Article Tools

* Image Usage & Resolution